Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
Reliance Retail acquired a majority 60% equity stake in Vitalic Health, parent of online pharmacy NetMeds, for ₹620 crore, gaining full control of subsidiaries. The move escalates e-pharmacy competition with Amazon, PharmEasy and MedLife amid regulatory uncertainty and druggist opposition.
What happened
Reliance Retail acquired 60% of Vitalic Health, parent of online pharmacy NetMeds, for ₹620 crore, gaining full control of subsidiaries and stepping up
Key facts
- 60% equity stake
- ₹620 crore
- 100% ownership of subsidiaries
- 20% stake by 2024
- FY20 net loss ₹184.3 crore
- NetMeds net loss ₹164.15 crore
- 19.59% ownership
Why this matters
This is a classic build-vs-buy shortcut—Reliance acquired NetMeds' licenses, fulfillment and pharmacist network rather than starting cold, signaling more bolt-on healthcare deals to fill its omnichannel stack.
What to watch
- Central e-pharmacy regulation/draft rules finalization
- AIOCD druggist protests or court injunctions
- Amazon Pharmacy and PharmEasy funding/expansion announcements
- NetMeds order volume and city coverage metrics post-integration
- Additional Reliance healthtech acquisitions or JV signals
- Integrate NetMeds SKUs and prescriptions into JioMart/MyJio app
- Leverage Reliance Retail physical stores as pharmacy fulfillment nodes
- Aggressive discounting and subscription bundling to grab share
- Pursue diagnostics/teleconsultation tuck-ins to build a health platform
- Lobby for favorable e-pharmacy regulatory framework